Foscarnet sodium is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus (CMV) retinitis in individuals with AIDS. Foscarnet sodium is also FDA-approved for the treatment of a certain type of herpes simplex virus (HSV)infection, called acyclovir-resistant mucocutaneous HSV infection, in people with weakened immune systems. CMV diseases—including those affecting the eye (retinitis)—and HSV diseases can be opportunistic infections (OIs) of HIV. It is grouped under the following drug class(es): DNA polymerase inhibitors. Its therapeutic use is listed as antivirals. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Foscavir and Triapten. Its PubChem CID is 44561.
Foscarnet sodium
| CAS No | 63585-09-1 |
|---|---|
| Molecular Formula | CNa3O5P |
| Molecular Weight | 191.95 g/mol |
| Synonyms | trisodium;phosphonatoformate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus (CMV) retinitis in individuals with AIDS.
The listed CAS number is 63585-09-1.
The listed molecular formula is CNa3O5P.
The listed molecular weight is 191.95 g/mol.
trisodium;phosphonatoformate.
The source lists Foscavir and Triapten.